An innovative company headed up by a scientist from Falkirk has been given a £70,000 Scottish Enterprise grant.
Big DNA, the vaccine development company based at Roslin Biocentre, near Edinburgh, received the SMART:Scotland innovation grant towards a £103,406 project. The awards are made to Scottish-based companies developing innovative technologies with high potential for growth and economic benefit.
Dr John March, BigDNA’s chief executive officer, whose parents live in Camelon, said the cash would enable the company to develop the ‘second generation’ form of its proprietary bacteriophage-based platform technology.
He said: “The platform will underpin a new pipeline of vaccine candidate products targeting infectious disease indications of high unmet medical and commercial need – we are delighted Scottish Enterprise has recognised the potential in this technology.”
Michael Cannon of Scottish Enterprise said: “Big DNA is a great example of an ambitious Scottish company keen to maximise its business growth opportunities. Scotland continues to produce exciting innovative young companies with emerging technology, products and services that boast global potential and we want to see more of them access the wide range of support we have to offer.”